Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Change in Accured Expenses (2020 - 2022)

Atea Pharmaceuticals has reported Change in Accured Expenses over the past 3 years, most recently at $1.5 million for Q4 2022.

  • Quarterly results put Change in Accured Expenses at $1.5 million for Q4 2022, down 85.98% from a year ago — trailing twelve months through Dec 2022 was -$37.6 million (down 185.75% YoY), and the annual figure for FY2025 was $12.7 million, up 194.26%.
  • Change in Accured Expenses for Q4 2022 was $1.5 million at Atea Pharmaceuticals, down from $2.5 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for AVIR hit a ceiling of $17.0 million in Q2 2021 and a floor of -$28.0 million in Q1 2022.
  • Median Change in Accured Expenses over the past 3 years was $2.8 million (2020), compared with a mean of $1.6 million.
  • Biggest five-year swings in Change in Accured Expenses: skyrocketed 1886.52% in 2021 and later tumbled 522.66% in 2022.
  • Atea Pharmaceuticals' Change in Accured Expenses stood at $8.2 million in 2020, then rose by 29.6% to $10.6 million in 2021, then plummeted by 85.98% to $1.5 million in 2022.
  • The last three reported values for Change in Accured Expenses were $1.5 million (Q4 2022), $2.5 million (Q3 2022), and -$13.6 million (Q2 2022) per Business Quant data.